By: Dyana Williams, Client Engagement Manager, Lighthouse RCM Solutions Presumptive drug testing screens for drug presence, while definitive testing identifies specific drugs and concentrations. Both aid in patient care and treatment decisions. In the world of...
By: Dyana Williams, Client Engagement Manager, LLS RCM Solutions For hospital-based pathology groups, mastering the complex revenue cycle management processes surrounding the capture and billing of Professional Component of Clinical Laboratory (PCCP) services is...
In the ongoing deployment of our RCM Spotlight denial management tool for our clients, a recurring trend has emerged: Timely filing consistently ranks among the top five denial reasons for both independent and hospital-based laboratories. Timely filing denials are a...
On July 1, 2023, the Centers for Medicare and Medicaid Services (“CMS”) implemented a new National Correct Coding Initiative (“NCCI”) Procedure-to-Procedure (“PTP”) edit for codes 80305, 80306, and 80307 for presumptive drug test(s), and codes G0480-G0483, and...
The 2024 Medicare Physician Fee Schedule Proposed Rule released July 13 is already generating pushback from lab and pathology advocates, such at the College of American Pathologists (CAP), who contend these services and the physicians who provide them cannot sustain...
Our latest denial spotlight uncovers how RCM Spotlight, a powerful, AI-assisted tool for revenue cycle and denial management, optimized billing processes for one of our independent lab clients to unlock nearly $200,000 in reimbursement opportunities for previously...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy